Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients

Table 2 Vital signs, clinical manifestations and biochemical data of the patients (n = 43)

Variables	Data
Vital signs
Heart rate (time/min), mean ± SD	87.2 ± 3.1
Systolic pressure (mmHg), median (Q1, Q3)	101.0 (94.5, 113.0)
Diastolic pressure (mmHg), mean ± SD	66.2 ± 1.7
Clinical manifestations
Fever (No/Yes)	26/17
Abdominal pain (No/Yes)	1/42
Diarrhea (No/Yes)	14/29
Fecal occult blood (No/Yes)	23/20
Mucus or bloody purulent stool (No/Yes)	28/15
Lose weight (≥ 5 kg) (No/Yes)	4/39
Abdominal mass (No/Yes)	29/14
Toxic megacolon (No/Yes)	41/2
Gastrointestinal hemorrhage (No/Yes)	29/14
Intestinal obstruction (No/Yes)	19/24
Intestinal perforation (No/Yes)	34/9
Perianal disease (No/Yes)	35/8
Extraintestinal manifestations (No/Yes)	27/16
Oral ulcer (Yes)	13
Pyoderma gangrenosum (Yes)	1
Peripheral spondyloarthritis (Yes)	6
Others (Yes)	2
Biochemical data
White blood cell (× 109/L), mean ± SD	6.7 ± 0.6
Neutrophil count (× 109/L), mean ± SD	4.6 ± 0.5
Hemoglobin (g/L), mean ± SD	103.6 ± 4.5
Platelets (× 109/L), mean ± SD	343.2 ± 25.7
Alanine aminotransferase (U/L), median (Q1, Q3)	11.0 (8.0, 14.0)
Aspartate aminotransferase (U/L), median (Q1, Q3)	14.0 (10.3, 18.8)
Albumin (g/L), mean ± SD	30.6 ± 1.5
Lactate dehydrogenase (U/L), median (Q1, Q3)	127.0 (102.0, 140.0)
Creatinine (μmol/L), mean ± SD	60.7 ± 3.0
Potassium (mmol/L), mean ± SD	3.8 ± 0.1
Prothrombin time (s), mean ± SD	12.2 ± 0.2
Activated partial thromboplastin time (s), median (Q1, Q3)	29.3 (26.5, 32.9)
C-reactive protein (g/L), median (Q1, Q3)	26.3 (16.3, 71.4)